Vor Biopharma pivots to telitacicept with $175M funding, eyeing multi-billion potential. Risks include dilution, regulatory ...

At the halfway mark last year, 97 layoff rounds were reported, marking a 32% year-over-year increase for the first half of ...

The collaboration marks an unprecedented move by a major CPG brand to bring kids into its R&D lab to develop a new flavor ...